MOLECULAR PARTNERS ADS/1 Cash Flow Reinvestment Rate
MOLECULAR PARTNERS ADS/1 cash flow reinvestment rate. MOLECULAR PARTNERS ADS/1 (6ML0) has a Cash Flow Reinvestment Rate of 0.86x as of December 2022, reinvesting €101.61 Million (capex €1.42 Million plus investments €-100.20 Million) from operating cash flow of €118.57 Million. Explore MOLECULAR PARTNERS ADS/1 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of MOLECULAR PARTNERS ADS/1 (2022–2022)
Cash flow reinvestment rate of MOLECULAR PARTNERS ADS/1 from 2022 to 2022. Historical reinvestment intensity for MOLECULAR PARTNERS ADS/1 across 1 annual periods. Explore MOLECULAR PARTNERS ADS/1 capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
MOLECULAR PARTNERS ADS/1 Cash Flow Reinvestment Rate by Year (2022–2022)
MOLECULAR PARTNERS ADS/1 cash flow reinvestment rate by year from 2022 to 2022. Year-by-year capital reinvestment analysis for MOLECULAR PARTNERS ADS/1. For the full cash flow conversion analysis, see 6ML0 operating cash flow.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.86x | €101.61 Million | €118.57 Million | €1.42 Million | — |